MCID: PNC056
MIFTS: 50

Pineocytoma

Categories: Rare diseases, Neuronal diseases, Endocrine diseases, Cancer diseases

Aliases & Classifications for Pineocytoma

MalaCards integrated aliases for Pineocytoma:

Name: Pineocytoma 53 59 55 73
Tumor of the Pineal Region 73
Pineal Gland Neoplasm 73
Pinealocytoma 53
Pinealoma 53

Classifications:

Orphanet: 59  
Rare neurological diseases


External Ids:

Orphanet 59 ORPHA251912
UMLS via Orphanet 74 C0917890
ICD10 via Orphanet 34 D44.5
UMLS 73 C0917890

Summaries for Pineocytoma

NIH Rare Diseases : 53 A pineocytoma is a tumor of the pineal gland, a small organ in the brain that makes melatonin (a sleep-regulating hormone). Pineocytomas most often occur in adults as a solid mass, although they may appear to have fluid-filled (cystic) spaces on images of the brain. Signs and symptoms of pineocytomas include headaches, nausea, hydrocephalus, vision abnormalities, and Parinaud syndrome. Pineocytomas are usually slow-growing and rarely spread to other parts of the body. Treatment includes surgery to remove the pineocytoma; most of these tumors do not regrow (recur) after surgery.

MalaCards based summary : Pineocytoma, also known as tumor of the pineal region, is related to pineoblastoma and pineal gland cancer. An important gene associated with Pineocytoma is ASMT (Acetylserotonin O-Methyltransferase), and among its related pathways/superpathways are Neuroscience and Neural Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Etoposide and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include pineal, brain and bone, and related phenotypes are hydrocephalus and nausea and vomiting

Wikipedia : 76 Pineocytoma, also known as a pinealocytoma, is a benign, slowly growing tumor of the pineal gland.... more...

Related Diseases for Pineocytoma

Diseases related to Pineocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 201)
# Related Disease Score Top Affiliating Genes
1 pineoblastoma 31.7 ASMT GFAP SAG SYP
2 pineal gland cancer 29.6 ASMT ENO2 GFAP SAG SYP TUBB3
3 pineal parenchymal tumor of intermediate differentiation 27.3 ASMT ENO2 RHO SAG SYP TUBB3
4 mixed type thymoma 10.6 S100B SYP
5 hypoganglionosis 10.6 S100B SYP
6 desmoplastic infantile ganglioglioma 10.6 GFAP SYP
7 extraventricular neurocytoma 10.6 GFAP SYP
8 rosette-forming glioneuronal tumor 10.6 S100B SYP
9 lung combined type small cell carcinoma 10.6 GFAP SYP
10 supratentorial primitive neuroectodermal tumor 10.6 S100B SYP
11 gangliocytoma 10.6 GFAP SYP
12 rhabdoid meningioma 10.6 GFAP SYP
13 pilomyxoid astrocytoma 10.6 GFAP SYP
14 chiari malformation 10.6 GFAP SYP
15 esophageal neuroendocrine tumor 10.5 CHGA SYP
16 ovarian large-cell neuroendocrine carcinoma 10.5 CHGA SYP
17 obstructive hydrocephalus 10.5 GFAP SYP
18 adenoma of the pancreas 10.5 CHGA SYP
19 medulloepithelioma 10.5 GFAP SYP
20 acinar cell cystadenocarcinoma 10.5 CHGA SYP
21 peritoneal serous adenocarcinoma 10.5 CHGA SYP
22 gemistocytic astrocytoma 10.5 GFAP S100B
23 gastrointestinal neuroendocrine tumor 10.5 CHGA SYP
24 childhood oligodendroglioma 10.5 GFAP SYP
25 syringocystadenoma papilliferum 10.5 GFAP S100B
26 spindle cell rhabdomyosarcoma 10.5 GFAP S100B
27 pancreatic serous cystadenoma 10.5 CHGA SYP
28 conventional angiosarcoma 10.5 CHGA SYP
29 myxopapillary ependymoma 10.5 GFAP S100B
30 chordoid glioma 10.5 GFAP S100B
31 syringoma 10.5 GFAP S100B
32 pulmonary sclerosing hemangioma 10.5 CHGA SYP
33 pancreatoblastoma 10.4 CHGA SYP
34 pulmonary blastoma 10.4 CHGA SYP
35 ureter, cancer of 10.4 CHGA SYP
36 malignant sertoli cell tumor 10.4 ENO2 SYP
37 non-functioning pancreatic endocrine tumor 10.4 CHGA SYP
38 sinonasal undifferentiated carcinoma 10.4 ENO2 SYP
39 sensory organ benign neoplasm 10.4 ENO2 SYP
40 perineurioma 10.4 GFAP S100B
41 ectopic cushing syndrome 10.4 S100B SYP
42 pancreatic somatostatinoma 10.4 ENO2 SYP
43 cutaneous ganglioneuroma 10.4 ENO2 SYP
44 extrahepatic bile duct adenocarcinoma 10.4 ENO2 SYP
45 papillary tumor of the pineal region 10.4 ENO2 SYP
46 orbital cancer 10.4 ENO2 SYP
47 middle ear adenoma 10.4 ENO2 SYP
48 cerebellopontine angle tumor 10.4 GFAP SYP
49 cerebellum cancer 10.4 ENO2 SYP
50 pancreatic cystadenocarcinoma 10.4 CHGA SYP

Graphical network of the top 20 diseases related to Pineocytoma:



Diseases related to Pineocytoma

Symptoms & Phenotypes for Pineocytoma

Human phenotypes related to Pineocytoma:

59 32 (show all 14)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 hydrocephalus 59 32 hallmark (90%) Very frequent (99-80%) HP:0000238
2 nausea and vomiting 59 32 hallmark (90%) Very frequent (99-80%) HP:0002017
3 headache 59 32 hallmark (90%) Very frequent (99-80%) HP:0002315
4 memory impairment 59 32 hallmark (90%) Very frequent (99-80%) HP:0002354
5 increased intracranial pressure 59 32 hallmark (90%) Very frequent (99-80%) HP:0002516
6 nystagmus 59 32 frequent (33%) Frequent (79-30%) HP:0000639
7 episodic ataxia 59 32 frequent (33%) Frequent (79-30%) HP:0002131
8 increased csf protein 59 32 frequent (33%) Frequent (79-30%) HP:0002922
9 altitudinal visual field defect 59 32 frequent (33%) Frequent (79-30%) HP:0030531
10 hearing abnormality 59 32 occasional (7.5%) Occasional (29-5%) HP:0000364
11 difficulty walking 59 32 occasional (7.5%) Occasional (29-5%) HP:0002355
12 abnormality of the eyelid 59 Frequent (79-30%)
13 cognitive impairment 59 Frequent (79-30%)
14 abnormal eyelid morphology 32 frequent (33%) HP:0000492

Drugs & Therapeutics for Pineocytoma

Drugs for Pineocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 167)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoposide Approved Phase 2, Phase 3,Phase 1,Not Applicable 33419-42-0 36462
2
Carboplatin Approved Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable 41575-94-4 10339178 498142 38904
3
Thiotepa Approved, Investigational Phase 2, Phase 3,Not Applicable 52-24-4 5453
4
Cyclophosphamide Approved, Investigational Phase 2, Phase 3,Phase 3,Not Applicable 50-18-0, 6055-19-2 2907
5
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
6
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
7
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
8
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
9
Isotretinoin Approved Phase 3,Not Applicable 4759-48-2 5538 5282379
10
Cisplatin Approved Phase 3,Not Applicable 15663-27-1 84093 441203 2767
11
Vincristine Approved, Investigational Phase 3,Not Applicable 2068-78-2, 57-22-7 5978
12 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
13 Dermatologic Agents Phase 3,Phase 2,Phase 1,Not Applicable
14 Etoposide phosphate Phase 2, Phase 3,Phase 1,Not Applicable
15 Analgesics Phase 3,Phase 2,Phase 1
16 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
17 Central Nervous System Depressants Phase 3,Phase 2
18 Adjuvants, Anesthesia Phase 3
19 Cholinergic Agents Phase 3,Phase 2
20 Cholinesterase Inhibitors Phase 3,Phase 2
21 Narcotics Phase 3
22 Neurotransmitter Agents Phase 3,Phase 2
23 Analgesics, Opioid Phase 3
24 Anesthetics Phase 3
25 Nootropic Agents Phase 3,Phase 2
26 Anesthetics, General Phase 3
27 Anesthetics, Intravenous Phase 3
28 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
29 Immunosuppressive Agents Phase 3,Phase 2,Phase 1,Not Applicable
30 Liver Extracts Phase 3,Phase 1,Phase 2
31 Antirheumatic Agents Phase 3,Phase 2,Phase 1,Not Applicable
32 Antimitotic Agents Phase 3,Phase 1,Not Applicable
33 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
34 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1,Not Applicable
35 Adjuvants, Immunologic Phase 3,Phase 1
36 Cola Nutraceutical Phase 3,Phase 1
37
Dacarbazine Approved, Investigational Phase 2,Phase 1 4342-03-4 5351166
38
Irinotecan Approved, Investigational Phase 2,Phase 1 97682-44-5, 100286-90-6 60838
39
Temozolomide Approved, Investigational Phase 2,Phase 1 85622-93-1 5394
40
Miconazole Approved, Investigational, Vet_approved Phase 2,Phase 1 22916-47-8 4189
41 Piracetam Approved, Investigational Phase 2 7491-74-9
42
Pregabalin Approved, Illicit, Investigational Phase 2 148553-50-8 5486971
43
Everolimus Approved Phase 2,Phase 1 159351-69-6 6442177
44
Bevacizumab Approved, Investigational Phase 2 216974-75-3
45
Sirolimus Approved, Investigational Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
46
Dasatinib Approved, Investigational Phase 2,Phase 1 302962-49-8 3062316
47
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
48
Benzocaine Approved, Investigational Phase 2 1994-09-7, 94-09-7 2337
49
Ethanol Approved Phase 2 64-17-5 702
50
Sorbitol Approved Phase 2 50-70-4 5780

Interventional clinical trials:

(show top 50) (show all 63)
# Name Status NCT ID Phase Drugs
1 Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors Unknown status NCT00179803 Phase 2, Phase 3
2 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
3 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
4 Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma Recruiting NCT00392327 Phase 3 Vincristine Sulfate;Carboplatin;Cisplatin;Cyclophosphamide;Isotretinoin
5 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Active, not recruiting NCT01987596 Phase 3
6 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
7 Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors Completed NCT00025077 Phase 2 carboplatin;cyclophosphamide;thiotepa
8 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
9 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors Completed NCT00629889 Phase 2 levetiracetam;pregabalin
10 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
11 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors Completed NCT00003461 Phase 1, Phase 2
12 Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma Recruiting NCT02596828 Phase 2 Temozolomide;Irinotecan;Dasatinib;Rapamycin
13 Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Active, not recruiting NCT01217437 Phase 2 Irinotecan Hydrochloride;Temozolomide
14 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
15 Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma Active, not recruiting NCT01977677 Phase 1, Phase 2 temozolomide;plerixafor
16 Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Suspended NCT00983398 Phase 1, Phase 2 Carboplatin;Mannitol;Melphalan;Sodium Thiosulfate
17 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
18 Stereotactic Radiosurgery in Treating Patients With Brain Tumors Completed NCT00019578 Phase 1
19 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1 Gamma-Secretase Inhibitor RO4929097;Temozolomide
20 A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors Completed NCT00784914 Phase 1 temsirolimus
21 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1 bortezomib;temozolomide
22 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Completed NCT00006368 Phase 1
23 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1 carboplatin
24 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
25 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas Completed NCT00019019 Phase 1 carboxyamidotriazole;paclitaxel
26 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
27 Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma Completed NCT01273090 Phase 1 imetelstat sodium
28 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Completed NCT01158300 Phase 1 VEGF inhibitor PTC299
29 Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors Completed NCT00003484 Phase 1 carmustine;irinotecan hydrochloride
30 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat
31 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1 vorinostat;temozolomide
32 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1 vorinostat;bortezomib
33 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1 veliparib;temozolomide
34 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1 Cediranib Maleate
35 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1 lenalidomide
36 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1 cilengitide
37 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1 O6-benzylguanine;temozolomide
38 SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors Recruiting NCT03434262 Phase 1 Gemcitabine;ribociclib;sonidegib;trametinib
39 Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Recruiting NCT02780804 Phase 1 Entinostat
40 Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Recruiting NCT02255461 Phase 1 palbociclib isethionate
41 Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Active, not recruiting NCT00638898 Phase 1 busulfan;melphalan;topotecan hydrochloride
42 Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors Terminated NCT00110032 Phase 1 EF5
43 Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Terminated NCT01088763 Phase 1 gamma-secretase/Notch signalling pathway inhibitor RO4929097;dexamethasone
44 A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Withdrawn NCT01182883 Phase 1 IMC-A12;Temsirolimus
45 Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Unknown status NCT00757614
46 Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging Completed NCT01884194
47 Study of Blood and Cheek Cell Samples From Patients With Glioma Completed NCT01009307
48 Study of Tissue Samples From Patients With Glioma or Other Brain Tumors Completed NCT00967200
49 Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors Completed NCT00499798
50 Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders Completed NCT00255671

Search NIH Clinical Center for Pineocytoma

Genetic Tests for Pineocytoma

Anatomical Context for Pineocytoma

MalaCards organs/tissues related to Pineocytoma:

41
Pineal, Brain, Bone, Spinal Cord, Bone Marrow, Endothelial, T Cells

Publications for Pineocytoma

Articles related to Pineocytoma:

(show top 50) (show all 94)
# Title Authors Year
1
Papillary tumor of the pineal region: Case report and review of the literature. ( 29691144 )
2018
2
Papillary tumor of the pineal region in children: presentation of a case and comprehensive literature review. ( 29906576 )
2018
3
Nuclear CRX and FOXJ1 Expression Differentiates Non-Germ Cell Pineal Region Tumors and Supports the Ependymal Differentiation of Papillary Tumor of the Pineal Region. ( 28719464 )
2017
4
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity. ( 26113311 )
2016
5
Late dissemination via cerebrospinal fluid of papillary tumor of the pineal region: a case report and literature review. ( 27179224 )
2016
6
Increased VEGF levels in one case of papillary tumor of the pineal region with intracranial haemorrhage at presentation: a potential surrogate indicator of tumor angiogenesis and aggressiveness? ( 26745494 )
2016
7
Cytologic features of papillary tumor of the pineal region: A case report showing tigroid background. ( 27535020 )
2016
8
A case of papillary tumor of the pineal region with a long clinical history: molecular characterization and therapeutic consideration with review of the literature. ( 27472995 )
2016
9
Atypical Teratoid/Rhabdoid Tumor of the Pineal Region in a Young Adult Male Patient: Case Report and Review of the Literature. ( 27144539 )
2016
10
Progressive supranuclear palsy motor phenotype in a patient with pineocytoma. ( 27432179 )
2016
11
Long-term follow-up of a papillary tumor of the pineal region: addendum to a case report. ( 27568037 )
2016
12
Papillary tumor of the pineal region with extended clinical and radiologic follow-up. ( 26539320 )
2015
13
Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region. ( 26125673 )
2015
14
Papillary tumor of the pineal region-report of three cases with literature review. ( 26238893 )
2015
15
Papillary tumor of the pineal region presenting with Foster Kennedy sign. ( 26183673 )
2015
16
Papillary tumor of the pineal region: A case report and review of the literature. ( 26622493 )
2015
17
Papillary tumor of the pineal region: Histopathological characterization and review of the literature. ( 24556386 )
2015
18
Papillary tumor of the pineal region with synchronous suprasellar focus and novel cytogenetic features. ( 26068071 )
2015
19
Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. ( 25749579 )
2015
20
Papillary Tumor of the Pineal Region: MR Signal Intensity Correlated to Histopathology. ( 25688307 )
2015
21
Is CRX protein a useful marker in differential diagnosis of tumors of the pineal region? ( 24555912 )
2014
22
Papillary tumor of the pineal region. Report of two cases and literature review. ( 25440015 )
2014
23
PTEN mutations and activation of the PI3K/Akt/mTOR signaling pathway in papillary tumors of the pineal region. ( 25003235 )
2014
24
Stereotactic radiosurgery of a papillary tumor of the pineal region: case report and review of the literature. ( 23446182 )
2013
25
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report. ( 24019784 )
2013
26
CRX/OTX3: a useful marker in the differential diagnosis of tumors of the pineal region and indicator of photoreceptor differentiation in medulloblastomas and atypical teratoid rhabdoid tumors. ( 23235340 )
2013
27
Papillary tumor of the pineal region with anaplastic small cell component. ( 23817812 )
2013
28
Early treatment response of a rare papillary tumor of the pineal region after primary proton-beam therapy using the raster-scanning technique at HIT. ( 23235766 )
2012
29
Sleep disturbance after pinealectomy in patients with pineocytoma WHOA^I. ( 22706841 )
2012
30
Histopathologic and ultrastructural features and claudin expression in papillary tumors of the pineal region: a multicenter analysis. ( 22588068 )
2012
31
Familial pineocytoma. ( 22699425 )
2012
32
Pleomorphic pineocytoma associated with normal pineal parenchyma: report of a case in a 70-year-old man. ( 20573029 )
2011
33
Pineocytoma in a lowland anoa (Bubalus depressicornis). ( 20961555 )
2011
34
Contemporary management of pineocytoma. ( 21801989 )
2011
35
Pineocytoma with diffuse dissemination to the leptomeninges. ( 22355508 )
2011
36
Atypical teratoid/rhabdoid tumor of the pineal region in an adult. ( 19911885 )
2010
37
Tumor control after surgery and radiotherapy for pineocytoma. ( 20136388 )
2010
38
Factors influencing overall survival rates for patients with pineocytoma. ( 20461445 )
2010
39
In-111 pentetreotide in recurrent pineocytoma. ( 19352270 )
2009
40
Clinicopathological features from long-term observation of a papillary tumor of the pineal region (PTPR): a case report. ( 19856220 )
2009
41
Papillary tumor of the pineal region--a recently described entity: a report of three cases and review of the literature. ( 19642509 )
2009
42
Papillary tumor of the pineal region: a case report. ( 18987834 )
2008
43
Pineocytoma and pineal parenchymal tumors of intermediate differentiation presenting cytologic pleomorphism: a multicenter study. ( 18371183 )
2008
44
Pineocytoma mimicking a pineal cyst on imaging: true diagnostic dilemma or a case of incomplete imaging? ( 17925371 )
2008
45
Papillary pineocytoma in child: a case report. ( 17690754 )
2007
46
Microarray analysis reveals differential gene expression patterns in tumors of the pineal region. ( 16825954 )
2006
47
Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases. ( 17021405 )
2006
48
Pineal parenchymal tumours: I. Pineocytoma: a tumour responsive to platinum-based chemotherapy. ( 15214646 )
2004
49
Papillary neuroepithelial tumor of the pineal region. A case report. ( 15221340 )
2004
50
Pathology case of the month. Tumor of the pineal region. Pineoblastoma, recurrent. ( 15233382 )
2004

Variations for Pineocytoma

Expression for Pineocytoma

Search GEO for disease gene expression data for Pineocytoma.

Pathways for Pineocytoma

GO Terms for Pineocytoma

Cellular components related to Pineocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 photoreceptor inner segment GO:0001917 8.8 ENO2 RHO SAG

Biological processes related to Pineocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to light stimulus GO:0009416 9.37 AANAT RHO
2 regulation of rhodopsin mediated signaling pathway GO:0022400 9.32 RHO SAG
3 regulation of neuronal synaptic plasticity GO:0048168 9.26 S100B SYP
4 rhodopsin mediated signaling pathway GO:0016056 9.16 RHO SAG
5 indolalkylamine biosynthetic process GO:0046219 8.96 AANAT ASMT
6 melatonin biosynthetic process GO:0030187 8.62 AANAT ASMT

Sources for Pineocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....